Home / Science / AI Fuels Dog's Cancer Fight, Gains Altman's Praise
AI Fuels Dog's Cancer Fight, Gains Altman's Praise
30 Mar
Summary
- AI helped design a personalized cancer treatment for a dog.
- The dog's cancer is now in partial remission with a shrunk tumor.
- Sam Altman praised the dog owner's innovative use of AI.
An Australian man, Paul Conyngham, used artificial intelligence to spearhead a personalized experimental treatment for his dog Rosie's mast cell cancer. Conyngham extensively utilized AI chatbots like ChatGPT and Gemini for in-depth research into cancer therapies. He then employed AI tools to analyze Rosie's genome and understand mutated genes, leading to a custom mRNA vaccine and immunotherapy administered in December.
Rosie's cancer is now in partial remission, with her primary tumor considerably reduced and her mobility improved. The innovative approach, which involved sequencing Rosie's genome for $3,000 and seeking expert advice via AI recommendations, has garnered attention from OpenAI CEO Sam Altman. While experts note AI's potential to accelerate medical research, they emphasize that this was not a clinical trial and the exact impact of AI remains under scrutiny pending further scientific publication.
The journey began after Rosie's cancer was initially misdiagnosed as a rash. Following unsuccessful conventional treatments, Conyngham turned to AI for advanced options like mRNA therapeutics. He collaborated with scientists at the University of New South Wales and the University of Queensland to bring the treatment to fruition. Although the largest tumor responded well, other tumors required further intervention, and the long-term prognosis is uncertain.
